BRCA1 and prostate carcinoma: As the clinical course of prostate cancer in men with LP/P BRCA1/2 variants may be worse, the detection of low-grade cancer in men with LP/P BRCA1/2 variants needs to be weighed against the treatment outcomes [22, 23].